A maximum bias of 20% compared to the nontreated QC2 was set as the acceptance criterion. infectious disease, killing nearly 1 million people each year. The development of a protective vaccine against malaria is LY 345899 considered a high priority
J
J. the megamolecule approach to synthesize anti-HER2 nanobodyCcytosine deaminase conjugates with tunable numbers of nanobody and enzyme domains in a single, covalent molecule. Linking two nanobody domains to one enzyme domain improved avidity to a human cancer cell line by